March 14, 2019
…School of Medicine and hematologist-oncologist at Rady Children’s Hospital-San Diego, went through the NCLAM program in 2017 and was among the first cohort to participate in HCOE in 2018. “Besides helping me to navigate the UC San Diego system, the HCOE program gave me a support network and sense of…
June 18, 2020
…Dr. Ball, a prominent hematologist-oncologist and director of the Blood and Marrow Transplant (BMT) Program at UC San Diego Health, when I was first diagnosed with lymphoma three years ago, and I’m alive today because of his care,” said Shillman, who is founder, chairman and chief culture officer of Cognex…
November 3, 2015
Patients with unexplained low blood counts and abnormally mutated cells who do not fit the diagnostic criteria for recognized blood cancers should be described as having clonal cytopenias of undetermined significance, suggest UC San Diego School of Medicine researchers in a recent paper. The researchers found the condition surprisingly common…
May 4, 2016
Researchers at University of California San Diego School of Medicine have demonstrated that distinct types of glioblastoma, the most common form of brain cancer in adults, tend to develop in different regions of the brain. This finding provides an explanation for how the same cancer-causing mutation can give rise to…
June 3, 2021
As the first designated medical center in San Diego certified to offer this type of immunotherapy, UC San Diego Health will begin treating patients this month.
March 21, 2022
UC San Diego Health is now administering Evusheld to eligible, immunocompromised patients to protect against the COVID-19 virus.
December 12, 2022
UC San Diego Health has been awarded the prestigious 2022 California Association of Public Hospitals and Health Systems Quality Leaders Award in the category of health equity.
March 7, 2023
UC San Diego researchers delve deep into the unknown cause of pediatric acute myeloid leukemia to identify a gene splicing dysregulation and potential target for treating the disease, which often becomes treatment-resistant.
